Frequency News and Research

RSS

Curie-Cancer inks partnership agreements with Meiogenix to develop SpiX technology

Curie-Cancer, the body responsible for developing Institut Curie's industry partnership activity, today announces two three-year partnership agreements with Meiogenix, a French SME. Meiogenix develops SpiX technology under license from Institut Curie and Institut National de la Recherche Agronomique.

19 Nov 2013

Experts develop new working formulation for reporting of cardiac antibody-mediated rejection

Antibody-mediated rejection of the transplanted heart is a recognized clinical complication and a major limitation to survival of patients who have undergone heart transplantation. Experts have now developed a new working formulation for the pathologic diagnosis, grading, and reporting of cardiac antibody-mediated rejection.

18 Nov 2013

Study shows patients at high-risk of CNV benefit from ForeseeHome device for earlier detection

The results of the Home Monitoring of the Eye (HOME) study, conducted in Age-Related Eye Disease Study 2 (AREDS2) clinical centers, executed by the EMMES Corporation and sponsored by Notal Vision Ltd. Tel Aviv, Israel, have been accepted for publication in Ophthalmology.

16 Nov 2013

Errors in medication common on admission to mental health services, shows study

A recent study, published in the International Journal of Clinical Pharmacy, involving Aston University (UK), South Essex Partnership University NHS Foundation Trust (SEPT) and the University of East Anglia (UK) found medication errors were common on admission to mental health services.

16 Nov 2013

Studies prove that students use prescription drugs to enhance cognitive performance

American and European studies prove that students use prescription medication or drugs to enhance their cognitive performance. Researchers from the universities of Zurich and Basel examined whether Swiss students have also experimented with neuroenhancement and which substances they take by conducting a survey of 6,725 students with an average age of 23 at the two universities and ETH Zurich.

16 Nov 2013

Competitive gymnasts have higher exposure to harmful flame-retardants, shows study

Competitive gymnasts have a higher exposure to potentially harmful flame-retardants than the general population, likely because such contaminants are present in foam used in gym equipment, a study led by Boston University School of Public Health researchers has found.

15 Nov 2013

Diabetes people with low levels of physical activity are at greater risk of cardiovascular disease

The risk of cardiovascular complications in people with type 2 diabetes is directly related to the frequency and duration of physical exercise, according to results of a large follow-up study reported today on World Diabetes Day. Notably, those with low levels of physical activity had a 70% greater risk of cardiovascular death than those with higher levels.

15 Nov 2013

Researchers use new approach to parse roles of key mutated protein that causes familial AD

Researchers at the University of California, San Diego School of Medicine have used genetic engineering of human induced pluripotent stem cells to specifically and precisely parse the roles of a key mutated protein in causing familial Alzheimer's disease, discovering that simple loss-of-function does not contribute to the inherited form of the neurodegenerative disorder.

15 Nov 2013

NeuroPace RNS System gets premarket approval from FDA for treatment of partial onset seizures

NeuroPace, Inc. today announced that the U.S. Food and Drug Administration has granted premarket approval for the NeuroPace RNS System, a treatment for adults with partial onset seizures that have not been controlled with two or more antiepileptic drugs.

14 Nov 2013

Medical device to reduce frequency of seizures in epilepsy patients gets FDA approval

The U.S. Food and Drug Administration today approved a device to help reduce the frequency of seizures in epilepsy patients who have not responded well to medications.

14 Nov 2013

The LGL Group third quarter 2013 total revenues decrease 16.5%

The LGL Group, Inc., announced results for the three and nine months ended September 30, 2013.

14 Nov 2013

Leading pediatric health system to examine causes of divergence and variability

The Department of Defense has awarded Nemours a $3.9 million grant to evaluate how physicians use best practice guidelines and to consider strategies to maintain clinical skills and consistency of care. The study, which will examine care provided throughout Nemours' pediatric health system, could help the military reintegrate physicians after deployment and better understand how their time away from routine practice affects their clinical knowledge and skill.

14 Nov 2013

Researchers use bioelectrical impedance analysis ratios to assess Lymphedema in breast cancer patients

Viewed as one of the most feared outcomes of breast cancer treatment, doctors struggle detecting and diagnosing breast-cancer related Lymphedema--a condition affecting the lymphatic system and causing psychosocial distress and physical challenges for patients.

13 Nov 2013

Nursing homes may not need to turn residents every 2 hours to prevent pressure ulcers

A study led by Nancy Bergstrom, Ph.D., associate dean at The University of Texas Health Science Center at Houston (UTHealth) School of Nursing, found that nursing homes that utilize high-density foam mattresses may not need to turn residents every two hours to prevent pressure ulcers, a practice that has been used for over 50 years.

13 Nov 2013

FDA Advisory Committee votes in favor of Cochlear Nucleus Hybrid L24 Implant System

Cochlear Limited, the global leader in implantable hearing solutions, announced today that an advisory committee to the US Food and Drug Administration voted favorably on the Cochlear Nucleus Hybrid L24 Implant System.

12 Nov 2013

Study reports increased frequency of nail gun-associated injuries in work-related settings

Young males in the work environment are at greatest risk of sustaining a nail gun injury to their non-dominant hand, a new study has found.

11 Nov 2013

A*STAR scientists discover potential target to weed out progression of cancer

Scientists at A*STAR have discovered an enzyme, Wip1 phosphatase, as a potential target to weed out the progression of cancer. Although studies in the past have revealed that this enzyme plays a critical role in regulating the budding of tumours, scientists have for the first time unearthed a mechanism for its mode of action.

10 Nov 2013

Frequency News and Research

Curie-Cancer inks partnership agreements with Meiogenix to develop SpiX technology

Experts develop new working formulation for reporting of cardiac antibody-mediated rejection

Study shows patients at high-risk of CNV benefit from ForeseeHome device for earlier detection

Errors in medication common on admission to mental health services, shows study

Studies prove that students use prescription drugs to enhance cognitive performance

Competitive gymnasts have higher exposure to harmful flame-retardants, shows study

Diabetes people with low levels of physical activity are at greater risk of cardiovascular disease

Researchers use new approach to parse roles of key mutated protein that causes familial AD

NeuroPace RNS System gets premarket approval from FDA for treatment of partial onset seizures

Medical device to reduce frequency of seizures in epilepsy patients gets FDA approval

The LGL Group third quarter 2013 total revenues decrease 16.5%

Leading pediatric health system to examine causes of divergence and variability

Researchers use bioelectrical impedance analysis ratios to assess Lymphedema in breast cancer patients

Nursing homes may not need to turn residents every 2 hours to prevent pressure ulcers

FDA Advisory Committee votes in favor of Cochlear Nucleus Hybrid L24 Implant System

Study reports increased frequency of nail gun-associated injuries in work-related settings

A*STAR scientists discover potential target to weed out progression of cancer

Coding variants in immune disease-related genes play only small part in risk for psoriasis

New research describes neural mechanism by which sleeping brain locks in learning visual task

Aptiom receives FDA approval to treat seizures associated with epilepsy

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News